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The National Institutes of Health Stroke Scale (NIHSS) score has been used in thrombolysis trials to include 
or exclude patients from active treatment, but there is some 
controversy regarding whether the NIHSS score is useful to 
predict vessel occlusion (VO) as seen on arteriography.1–5 
The aim of the present study was to test the association of 
the NIHSS score and arterial occlusion on MR arteriography 
(MRA) and CT arteriography (CTA).
Materials and Methods
This study was based on the Bernese stroke database. We analyzed 
2152 patients recorded from January 2004 to December 2011. They 
all presented within 24 hours, with a neurological deficit attributable 
to stroke or transient ischemic attack and had adequate MRA or CTA 
for analysis.
Patients with and without clearly known time of symptom onset 
were listed and analyzed separately. Clinical assessment was per-
formed by a stroke neurologist after admission using the NIHSS 
score.6 Immediately thereafter, all patients underwent MRA 
(n=1603/74.5%) or CTA (n=549/25.5%), which confirmed acute 
ischemic lesions and the site of any VOs if present. All images were 
reviewed both by a neuroradiologist and neurologist blinded to clini-
cal signs and NIHSS scores. Patients in coma were excluded.
Patients were assigned to subgroups according to the location of 
their VOs. Central VO was defined as VO of the internal carotid ar-
tery, main stem and branch of the middle cerebral artery (M1/M2), 
basilar artery or intracranial vertebral artery (V4), peripheral VO as 
VO of the anterior cerebral, posterior cerebral, superior cerebellar, 
anterior inferior cerebellar, or posterior inferior cerebellar artery, or 
peripheral branches of the middle cerebral artery (M3/M4).
Statistical Analysis
We calculated the positive predictive values (PPV), sensitivities 
(sens) and specificities (spec), odds ratios, and receiver operating 
characteristic curves for the NIHSS scores to predict VOs. To assess 
significance we used the χ2 test.
Our institutional review board approved our stroke database and 
this analysis.
Background and Purpose—There is some controversy on the association of the National Institutes of Health Stroke Scale 
(NIHSS) score to predict arterial occlusion on MR arteriography and CT arteriography in acute stroke.
Methods—We analyzed NIHSS scores and arteriographic findings in 2152 patients (35.4% women, mean age 66±14 years) 
with acute anterior or posterior circulation strokes.
Results—The study included 1603 patients examined with MR arteriography and 549 with CT arteriography. Of those, 
1043 patients (48.5%; median NIHSS score 5, median time to clinical assessment 179 minutes) showed an occlusion, 
887 in the anterior (median NIHSS score 7/0–31), and 156 in the posterior circulation (median NIHSS score 3/0–32). 
Eight hundred sixty visualized occlusions (82.5%) were located centrally (ie, in the basilar, intracranial vertebral, internal 
carotid artery, or M1/M2 segment of the middle cerebral artery). NIHSS scores turned out to be predictive for any vessel 
occlusions in the anterior circulation. Best cut-off values within 3 hours after symptom onset were NIHSS scores ≥9 
(positive predictive value 86.4%) and NIHSS scores ≥7 within >3 to 6 hours (positive predictive value 84.4%). Patients 
with central occlusions presenting within 3 hours had NIHSS scores <4 in only 5%. In the posterior circulation and in 
patients presenting after 6 hours, the predictive value of the NIHSS score for vessel occlusion was poor.
Conclusions—There is a significant association of NIHSS scores and vessel occlusions in patients with anterior circulation 
strokes. This association is best within the first hours after symptom onset. Thereafter and in the posterior circulation the 
association is poor.   (Stroke. 2013;44:1153-1157.)
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Results
The study included 2152 patients; 2018 (93.8%) had acute 
ischemic strokes and 134 (6.2%) had transient ischemic 
attacks. Their mean age was 66 years±14 years; 762 (35.4%) 
were women. Six hundred ninety-six patients (32.34%) pre-
sented within 3 hours, 650 (30.2%) within 3 to 6 hours, 216 
(10.04%) from 6 to 24 hours, and in 590 patients (27.42%) 
time of symptom onset was unknown, but presentation was 
within 24 hours. In addition, 1599 patients had anterior cir-
culation (AC) and 553 posterior circulation (PC) events. 
Median time to clinical assessment was 179±265 minutes 
(AC: 161±244 minutes; PC: 248±305 minutes; P<0.0001). 
Furthermore, 1043 patients (48.5%) showed a VO on MRA or 
CTA, 887 in the AC and 156 in the PC. Eight hundred sixty 
VOs were central, 775 in the AC and 85 in the PC. In 1109 
patients (51.5%), 712 with AC and 397 with PC events, MRA 
or CTA did not reveal any VO. Baseline characteristics and 
radiological findings are shown in supplemental file I (in the 
online-only Data Supplement).
High NIHSS scores were associated with VOs (P<0.0001). 
The probability of VOs increased as NIHSS scores became 
greater. Before 6 hours, the probability of VOs at NIHSS 
scores 9 to 12 was 6.4- to 8-fold in AC and 4- to 5.5-fold 
higher in PC events compared with lower NIHSS scores of 0 
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Figure 1. Distribution of the National 
Institutes of Health Stroke Scale 
(NIHSS) scores of all patients. Each 
NIHSS score category contains the 
number of patients with central, periph-
eral, or without visible vessel occlu-
sions (in percent of the total number 
of patients). A, Total cohort of patients 
(n=2152=100%). B, Patients assessed 
within 0 to 3 hours after symptom 
onset (n=696=100%). C, Patients 
assessed within >3 to 6 hours after 
symptom onset (n=650=100%).
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to 4. Central VOs at NIHSS scores 9 to 12 were 7.3- to 9-fold 
more likely than at NIHSS scores of 0 to 4 (supplemental file 
II in the online-only Data Supplement). Receiver operating 
characteristic curves analyzing the validity of NIHSS scores 
in predicting AC, PC, and central VOs are shown in supple-
mental file III (in the online-only Data Supplement).
Figure 1 shows an increasing number of both any VO and 
central VO at increasing NIHSS scores. The sensitivity and 
specificity of the NIHSS score to predict VOs is shown in 
Figure 2. The best NIHSS score cut-off to find any VO was 
6 (PPV 73%), in the AC within 3 hours 9 (PPV 86.4%), and 
within >3 to 6 hours 7 (PPV 84.4%). PPV beyond 6 hours and 
in the PC to show a VO was poor. The best NIHSS score cut-off 
to show a central VO within 3 hours was 9 (PPV 80.7%) and 
within >3 to 6 hours 7 (PPV 77%). After 6 hours the predictive 
value was almost as poor as for any VO. In addition, 91.2% of 
patients with peripheral or without visible VOs presented with 
NIHSS scores ≤10. Within 0 to 3 hours, 13.2% of patients with 
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Figure 2. Sensitivity and specificity of National Insti-
tutes of Health Stroke Scale (NIHSS) scores to find any 
vessel occlusion in anterior (A) and posterior (B) circu-
lation events and to find a central vessel occlusion (C).
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NIHSS scores <9 had central VOs, and within >3 to 6 hours 
8.6% of patients with NIHSS scores <7 (Figure 1). Figure 3 
shows the cumulative percentage of patients missed with cen-
tral VOs.
Discussion
Previous studies on the association of the NIHSS score and 
VO were somehow conflicting. In patients with severe strokes 
undergoing digital subtraction arteriography for endovascular 
treatment, optimal cut-offs for VOs were higher than in this 
study.5 Olavarría et al4 found a time-dependent association, 
good before but poor after 6 hours from symptom onset. Maas 
et al3 reported a poor sensitivity of CTA to detect central VOs 
at an average of 7.5 hours. Our analysis of 2152 patients with 
acute ischemic events shows a significant association of NIHSS 
scores and VOs as seen on MRA and CTA. This association is 
time-dependent and best within the first hours after symptom 
onset. In addition, this association is good in the AC but poor 
in the PC.
The question arises whether there is any use of the NIHSS 
score to predict VO in acute ischemic stroke. To date, small 
randomized trials showed the effectiveness of intra-arterial 
thrombolysis in proximal middle cerebral artery occlusion.2 
In addition, bridging intravenous to endovascular therapy 
and retrievable stents might provide even better results.7–9 
Therefore, in stroke networks it is important to triage patients 
for intravenous or endovascular treatment strategies as early 
as possible. For triage purposes, the NIHSS score can be use-
ful, especially in smaller hospitals without access to emer-
gency vessel imaging.
A
B
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30
cu
m
ul
at
iv
e 
%
 o
f p
at
ie
nt
s 
w
ith
 c
en
tr
al
 o
cc
lu
si
on
s 
m
is
se
d
NIHSS score
time-delay 0-6 hours (n
total=1081, n central
occlusions=614)
time-delay >6-24 hours (n
total=117, n central
occlusions=30)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30
cu
m
ul
at
iv
e 
%
 o
f p
at
ie
nt
s 
w
ith
 c
en
tr
al
 o
cc
lu
si
on
s 
m
is
se
d
NIHSS score
time-delay 0-6 hours (n
total=265, n central
occlusions=54)
time-delay >6-24 hours (n
total=99, n central
occlusions=9)
Figure 3. Cumulative percentage of patients with 
central occlusions missed at various National Insti-
tutes of Health Stroke Scale (NIHSS) scores in the 
anterior (A) and posterior (B) circulation within 0 to 
6 hours and >6 to 24 hours.
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The main limitation of this study refers to the selection of 
patients. Because our center gets referrals from >40 hospitals, 
patients with large VOs are probably over-represented.
In conclusion, there is a significant association of NIHSS 
scores and VOs in patients with AC strokes. This association is 
time-dependent. It is best within the first hours after symptom 
onset. Thereafter and in the PC the association is poor.
 Acknowledgments
We thank Pietro Ballinari, PhD, for statistical advice.
Sources of Funding
Drs Heldner, Mattle, and Fischer were supported by a Swiss Heart 
Foundation grant.
Disclosures
None.
References
 1. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, et al. 
Measurements of acute cerebral infarction: a clinical examination scale. 
Stroke. 1989;20:864–870.
 2. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-
arterial prourokinase for acute ischemic stroke. The PROACT II study: a 
randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. 
JAMA. 1999;282:2003–2011.
 3. Maas MB, Furie KL, Lev MH, Ay H, Singhal AB, Greer DM, et al. National 
Institutes of Health Stroke Scale score is poorly predictive of proximal 
occlusion in acute cerebral ischemia. Stroke. 2009;40:2988–2993.
 4. Olavarría VV, Delgado I, Hoppe A, Brunser A, Cárcamo D, Díaz-Tapia 
V, et al. Validity of the NIHSS in predicting arterial occlusion in cerebral 
infarction is time-dependent. Neurology. 2011;76:62–68.
 5. Fischer U, Arnold M, Nedeltchev K, Brekenfeld C, Ballinari P, Remonda 
L, et al. NIHSS score and arteriographic findings in acute ischemic 
stroke. Stroke. 2005;36:2121–2125.
 6. Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, et al. 
Improved reliability of the NIH Stroke Scale using video training. 
NINDS TPA Stroke Study Group. Stroke. 1994;25:2220–2226.
 7. Mazighi M, Meseguer E, Labreuche J, Amarenco P. Bridging therapy 
in acute ischemic stroke: a systematic review and meta-analysis. Stroke. 
2012;43:1302–1308.
 8. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, et al.; 
SWIFT Trialists. Solitaire flow restoration device versus the Merci 
Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, 
parallel-group, non-inferiority trial. Lancet. 2012;380:1241–1249.
 9. Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, et 
al.; TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy 
revascularisation of large vessel occlusions in acute ischaemic stroke 
(TREVO 2): a randomised trial. Lancet. 2012;380:1231–1240.
 at Universitaet Bern on April 14, 2014http://stroke.ahajournals.org/Downloaded from 
1 
 
 
 
 
 
 
ONLINE SUPPLEMENT 
 
 
Supplemental Table 1 (S1) 
 
Supplemental Table 2 (S2) 
 
Supplemental Figure (S3) 
 
Supplemental Imaging Methods 
 
 
2 
 
S1. 
 
Baseline characteristics and radiological findings 
 
Vascular risk factors, n/%  
 
 Arterial hypertension 1381/64.2%  
 Diabetes mellitus 352/16.4%  
 Hypercholesterolemia 1148/53.3%  
 Current cigarette smoking 463/21.5%  
 Former cigarette smoking 240/11.2%  
 Previous stroke 272/12.6%  
 Previous TIA 359/16.7%  
 Previous myocardial infarction 327/15.2%  
 Atrial fibrillation 461/21.4%  
Stroke/TIA etiology, n/% 
 
 Large artery disease 329/15.3% 
 Cardioembolism 647/30.1% 
 Small artery disease 142/6.6% 
 Other determined etiology  
(cervical artery dissection) 
173/8%  
(112) 
 Undetermined etiology 331/15.4% 
 Unknown etiology 355/16.5% 
 More than one potential cause 175/8.1% 
Symptom onset to clinical assessment, n/% 
 
 0-3 hours 
o Anterior circulation, n(n occlusions/%) 
o Posterior circulation, n(n occlusions/%) 
o Central occlusions 
 696/32.34% 
o 576(391/67.9%)  
o 120(57/47.5%) 
o 376 
 >3-6 hours 
o Anterior circulation, n(n occlusions/%) 
o Posterior circulation, n(n occlusions/%) 
o Central occlusions 
 650/30.2% 
o 505(321/63.6%) 
o 145(45/31%) 
o 292 
 >6-24 hours 
o Anterior circulation, n(n occlusions/%) 
o Posterior circulation, n(n occlusions/%) 
o Central occlusions 
 216/10.04% 
o 117(33/28.2%) 
o 99(15/15.2%) 
o 39 
 Unknown time-delay up to 24 hours 
o Anterior circulation, n(n occlusions/%) 
o Posterior circulation, n(n occlusions/%) 
o Central occlusions 
 590/27.42% 
o 401(142/35.4%) 
o 189(39/20.6%) 
o 153 
Any vessel occlusion site (median NIHSS/range), n/% 
 
 ICA (16/0-31) 
 M1 (15/0-30) 
 M2 
 M3/M4 
 ACA 
 BA (12/1-32) 
 V4 (2/0-17) 
 PCA 
 SCA, AICA or PICA (2/0-12) 
 283/27.1% 
 303/29.1% 
 189/18.1% 
 97/9.3% 
 15/1.4% 
 59/5.7% 
 26/2.5% 
 58/5.6% 
 13/1.2% 
 
 
3 
 
S2. 
 
Probability of any vessel occlusion in the anterior and posterior circulation in different 
NIHSS score groups according to time-delay from symptom onset to clinical 
assessment  
 
Anterior circulation 
 
 
Time-delay  NIHSS 
score 
groups 
Any occlusion, 
n(%) 
No visible 
occlusion, n(%) 
Odds 
ratio 
Univariate 
95% CI 
p 
0-3 hours 
 
 
 
0-4 
5-8 
9-12 
13-16 
≥17 
40(31.25) 
67(56.3) 
67(74.44) 
96(92.31) 
121(89.63) 
88(68.75) 
52(43.7) 
23(25.56) 
8(7.69) 
14(10.37) 
1.0  
2.84 
6.41 
26.4 
19.01 
 
1.68-4.77 
3.51-11.72 
11.72-59.48 
9.75-37.07 
 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
>3-6 hours 
 
 
 
0-4 
5-8 
9-12 
13-16 
≥17 
52(31.52) 
51(53.68) 
48(78.69) 
68(88.31) 
102(95.33) 
113(68.48) 
44(46.32) 
13(21.31) 
9(11.69) 
5(4.67) 
1.0  
2.52  
8.02 
16.42 
44.33 
 
1.5-4.24 
4.0-16.08 
7.61-35.42 
17.04-115.31 
 
0.0005 
<0.0001 
<0.0001 
<0.0001 
>6-24 hours 
 
 
 
0-4 
5-8 
9-12 
13-16 
≥17 
17(21.52) 
2(10) 
7(87.5) 
1(25) 
6(100) 
62(78.48) 
18(90) 
1(12.5) 
3(75) 
0(0) 
1.0 
0.41 
25.53 
1.22 
* 
 
0.09-1.92 
2.94-222.02 
0.12-12.44 
* 
 
0.255 
0.003 
0.869 
* 
Unknown time-
delay up to 24 
hours 
 
 
0-4 
5-8 
9-12 
13-16 
≥17 
33(15.71) 
17(22.97) 
25(67.57) 
24(70.59) 
43(93.48) 
177(84.29) 
57(77.03) 
12(32.43) 
10(29.41) 
3(6.52) 
1.0 
1.6 
11.17 
12.87 
76.88 
 
0.83-3.09 
5.11-24.43 
5.63-29.4 
22.52-262.5 
 
0.16 
<0.0001 
<0.0001 
<0.0001 
Posterior circulation 
 
 
Time-delay  NIHSS 
score 
groups 
Any occlusion, 
n(%) 
No visible 
occlusion, n(%) 
Odds 
ratio 
Univariate 
95% CI 
p 
0-3 hours 
 
 
 
0-4 
5-8 
9-12 
13-16 
≥17 
22(33.33) 
17(54.84) 
4(66.67) 
7(77.78) 
7(87.5) 
44(66.67) 
14(45.16) 
2(33.33) 
2(22.22) 
1(12.5) 
1.0  
2.43  
4.0 
7.0 
14.0 
 
1.01-5.81 
0.68-23.55 
1.34-36.55 
1.62-121.02 
 
0.046 
0.125 
0.021 
0.017 
>3-6 hours 
 
 
 
0-4 
5-8 
9-12 
13-16 
≥17 
13(15.29) 
13(41.94) 
8(50) 
6(85.71) 
5(83.33) 
72(84.71) 
18(58.06) 
8(50) 
1(14.29) 
1(16.67) 
1.0  
4.0 
5.54 
33.23 
27.69 
 
1.58-10.09 
1.76-17.39 
3.69-299.28 
2.99-256.72 
 
0.003 
0.003 
0.002 
0.004 
>6-24 hours 
 
 
 
0-4 
5-8 
9-12 
13-16 
≥17 
11(14.29) 
1(6.25) 
1(25) 
1(100) 
1(100) 
66(85.71) 
15(93.75) 
3(75) 
0(0) 
0(0) 
1.0  
0.4  
2.0 
* 
 
0.05-3.34 
0.19-21.0 
* 
 
0.398  
0.563 
* 
Unknown time-
delay up to 24 
hours 
 
 
0-4 
5-8 
9-12 
13-16 
≥17 
21(15.22) 
8(21.62) 
3(50) 
2(100) 
5(83.33) 
117(84.78) 
29(78.38) 
3(50) 
0(0) 
1(16.67) 
1.0  
1.54 
5.57 
* 
27.86 
 
0.62-3.82 
1.05-29.49 
* 
3.1-250.59 
 
0.355  
0.043 
* 
0.003 
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Central occlusion 
 
 
Time-delay  NIHSS 
score 
groups 
Central 
occlusion, 
n(%) 
No visible 
central 
occlusion, n(%) 
Odds 
ratio 
Univariate 
95% CI 
p 
0-3 hours 
 
 
 
0-4 
5-8 
9-12 
13-16 
≥17 
34(17.53) 
58(38.67) 
63(65.63) 
96(84.96) 
125(87.41) 
160(82.47) 
92(61.33) 
33(34.37) 
17(15.04) 
18(12.59) 
1.0  
2.97 
8.98 
26.57 
32.68 
 
1.81-4.87 
5.13-15.74 
14.09-50.14 
17.63-60.59 
 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
>3-6 hours 
 
 
 
0-4 
5-8 
9-12 
13-16 
≥17 
37(14.8) 
40(31.75) 
43(55.84) 
68(80.95) 
104(92.04) 
213(85.2) 
86(68.25) 
34(44.16) 
16(19.05) 
9(7.96) 
1.0  
2.68  
7.28 
24.47 
66.52 
 
1.60-4.47 
4.12-12.87 
12.81-46.72 
30.95-143.0 
 
0.0002 
<0.0001 
<0.0001 
<0.0001 
>6-24 hours 
 
 
 
0-4 
5-8 
9-12 
13-16 
≥17 
21(13.46) 
3(8.33) 
7(58.33) 
1(20) 
7(100) 
135(86.54) 
33(91.67) 
5(41.67) 
4(80) 
0(0) 
1.0  
0.584  
9.0 
1.61 
* 
 
0.16-2.08 
2.61-30.99 
0.17-15.08 
* 
 
0.407  
0.0005 
0.678 
* 
Unknown time-
delay up to 24 
hours 
 
 
0-4 
5-8 
9-12 
13-16 
≥17 
37(10.63) 
18(16.22) 
25(58.14) 
25(69.44) 
48(92.31) 
311(89.37) 
93(83.78) 
18(41.86) 
11(30.56) 
4(7.69) 
1.0  
1.63 
11.67 
19.1 
100.86 
 
0.89-2.99 
5.83-23.4 
8.7-41.96 
34.41-295.67 
 
0.117 
<0.0001 
<0.0001 
<0.0001 
* Odds ratio not defined as n=0 
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S3. A. 
 
 
 
ROC analysis: Anterior circulation: Any vessel occlusion versus no visible vessel occlusion.
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S3. B. 
 
 
 
ROC analysis: Posterior circulation: Any vessel occlusion versus no visible vessel occlusion.
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S3. C. 
 
 
 
ROC analysis: Central versus no visible central vessel occlusion.
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Supplemental Imaging Methods 
 
 
CTAs were acquired with 8 or 16 slice multidetector-row CT scanners.  
 
 
Contrast-enhanced MRAs of the neck and intracranial arteries and time-of-flight MRAs of the 
intracranial arteries were acquired on 1.5T or 3T MR scanners. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
